You can buy or sell CARA and other stocks, options, ETFs, and crypto commission-free!
Cara Therapeutics, Inc. Common Stock, also called Cara Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Read More Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
52 Week High
52 Week Low
— per share
Expected May 5, After Hours